Developmental changes in AT1 and AT2 receptor-protein expression in rats.
It has long been known that angiotensin type-1 receptors (AT1R) play a critical role in sympathetic regulation, cardiovascular activity, and hormone secretion under physiological and pathological states. On the other hand, the functional significance of angiotensin type-2 receptors (AT2R) is poorly understood. In a recent study we demonstrated that, in rats with chronic heart failure, AT1R protein expression was increased but AT2R expression was decreased in the rostral ventrolateral medulla (RVLM). This imbalance of angiotensin receptors contributed to sympatho-excitation in the heart failure state. In the current experiment, we measured AT1R and AT2R protein expressions in the brainstem, kidney and liver from male foetuses (3 days before birth), male neonates (3 days after birth), male and female adults (8 weeks) and male aged (28 months) rats by Western blot analysis. In the brainstem, we found that the foetuses and neonates exhibited a significantly lower AT2R protein expression compared with adult rats (foetus 0.08 ± 0.01, neonate 0.12 ± 0.01, male adult 0.25 ± 0.01, female adult 0.22 ± 0.02; n = 4 per group, p < 0.001 foetus and neonate compared with male or female adults). In contrast, the foetuses and neonates expressed significantly higher AT1R protein than that of the adults (foetus 0.64 ± 0.09, neonate 0.56 ± 0.01, male adult 0.13 ± 0.02, female adult 0.08 ± 0.02; n = 4 each group, p < 0.001 foetus and neonate compared with male and female adults). In the liver, the AT2R protein was also higher in foetus and neonate, than in adult rats. Interestingly, the foetal liver expressed higher AT1R protein compared with that of the neonate. In the kidney, AT2R expression was significantly increased with age (foetus 0.08 ± 0.01, neonate 0.19 ± 0.02, male adult 0.49 ± 0.04, female adult 0.90 ± 0.10; n = 4 per group, p < 0.01-0.001). AT1R expression, on the other hand, was higher in the foetuses than that in both neonate and male adults. This study provides data contrary to existing dogma that AT2R expression is higher in foetal life and low in adults, suggesting an involvement of a potentially important functional role for AT2R in adult animals and AT1R in foetal development and/or physiology.
Yu
Li
L
Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5850, USA.
Zheng
Mingqi
M
Wang
Wei
W
Rozanski
George J
GJ
Zucker
Irving H
IH
Gao
Lie
L
D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D001933:Brain Stem / Q000378:metabolism; D005260:Female; D018507:Gene Expression Regulation, Developmental; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism*; D044139:Receptor, Angiotensin, Type 2 / Q000378:metabolism*
D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2
Physiol Genomics. 2000 Jan 24;2(1):13-20
11015577
Braz J Med Biol Res. 2002 Sep;35(9):1001-15
12219172
Hypertension. 1996 Mar;27(3 Pt 2):760-5
8613237
J Renin Angiotensin Aldosterone Syst. 2009 Mar;10(1):1-8
19286752
Hypertension. 2000 Jan;35(1 Pt 2):155-63
10642292
Nature. 1995 Oct 26;377(6551):744-7
7477266
Am J Physiol. 1991 Sep;261(3 Pt 2):H667-70
1887916
Kidney Int. 1994 Oct;46(4):973-9
7861723
Nephrol Dial Transplant. 2002 Feb;17(2):195-8
11812862
Regul Pept. 2001 Mar 2;97(2-3):91-102
11164944
Nature. 1995 Oct 26;377(6551):748-50
7477267
Hypertension. 1996 Jul;28(1):91-7
8675270
J Comp Neurol. 2005 Dec 26;493(4):571-9
16304626
Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1507-14
14684369
Mol Biotechnol. 2003 May;24(1):27-39
12721494
Curr Opin Cardiol. 2005 Jul;20(4):264-9
15956821
South Med J. 2009 Oct;102(10 Suppl):S1-S12
19834426
J Hypertens. 2003 Aug;21(8):1429-43
12872031
Hypertension. 2002 May;39(5):1021-7
12019286
J Clin Invest. 1991 Sep;88(3):921-33
1885777
Blood Press. 2003;12(2):70-88
12797627
Endocr Rev. 2003 Jun;24(3):261-71
12788798
Prog Neurobiol. 2009 Apr;87(4):252-63
19428956
Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97
16870827
Biochem Biophys Res Commun. 1999 Apr 29;258(1):194-8
10222259
Am J Physiol Endocrinol Metab. 2000 Mar;278(3):E357-74
10710489
Clin Exp Pharmacol Physiol. 2008 Apr;35(4):386-90
18307726
Brain Res Dev Brain Res. 2003 Nov 12;145(2):169-76
14604757
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11440-4
1763058
Hypertension. 2008 Oct;52(4):708-14
18768398
Am J Physiol Renal Physiol. 2009 Jun;296(6):F1484-93
19244399
Biochem Biophys Res Commun. 1996 Nov 21;228(3):825-30
8941361
Am J Physiol. 1993 Aug;265(2 Pt 2):F264-71
8368335
Am J Physiol. 1995 May;268(5 Pt 2):F922-30
7771520
Brain Res Dev Brain Res. 2004 May 19;150(1):51-61
15126038
Peptides. 2005 Aug;26(8):1401-9
16042980
Circ Res. 1992 Dec;71(6):1482-9
1423940
J Hypertens. 1999 Dec;17(12 Pt 2):1873-7
10703883
J Clin Invest. 1995 Feb;95(2):651-7
7860748
Curr Opin Nephrol Hypertens. 2005 Jan;14(1):67-71
15586018
J Biol Chem. 1996 Sep 13;271(37):22729-35
8798447
Vasc Health Risk Manag. 2007;3(1):125-37
17583183
Hypertension. 2000 May;35(5):1069-73
10818066
Pharmacol Rev. 2000 Sep;52(3):415-72
10977869
Regul Pept. 2001 Jun 15;99(2-3):175-82
11384780
Hypertension. 1997 Sep;30(3 Pt 1):358-62
9314417
Mol Cell Endocrinol. 1996 Aug 30;122(1):59-67
8898348
Am J Physiol. 1991 Jul;261(1 Pt 2):R209-16
1858948
Exp Physiol. 2008 May;93(5):519-27
18310257
Curr Med Res Opin. 2010 Jan;26(1):213-22
19921961
Physiol Rev. 2006 Jul;86(3):747-803
16816138